Christopher Gibson - 27 Mar 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Kyle Nelson, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
27 Mar 2025
Net transactions value
-$836,987
Form type
4
Filing time
28 Mar 2025, 16:52:57 UTC
Previous filing
07 Mar 2025
Next filing
19 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Sale $836,987 -138,574 -11% $6.04 1,117,450 27 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RXRX Class B Common Stock 5,896,700 27 Mar 2025 Class A Common Stock 5,896,700 $0.000000 Direct F2
holding RXRX Class B Common Stock 486,000 27 Mar 2025 Class A Common Stock 0 $0.000000 by LAHWRAN-3 LLC F2, F3
holding RXRX Class B Common Stock 388,000 27 Mar 2025 Class A Common Stock 0 $0.000000 by LAHWRAN-4 LLC F2, F4
holding RXRX Class B Common Stock 67,875 27 Mar 2025 Class A Common Stock 0 $0.000000 by Gibson Family Trust F2, F5
holding RXRX Stock Option (Right to Buy) 1,050,567 27 Mar 2025 Class A Common Stock 0 $7.25 Direct F6
holding RXRX Stock Option (Right to Buy) 666,898 27 Mar 2025 Class A Common Stock 0 $10.09 Direct F7
holding RXRX Stock Option (Right to Buy) 813,600 27 Mar 2025 Class A Common Stock 0 $8.55 Direct F8
holding RXRX Stock Option (Right to Buy) 399,002 27 Mar 2025 Class A Common Stock 0 $11.40 Direct F9
holding RXRX Stock Option (Right to Buy) 5,436 27 Mar 2025 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 282,500 27 Mar 2025 Class A Common Stock 0 $2.48 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2024.
F2 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F3 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F4 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F5 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F6 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F7 The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F8 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F9 The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F10 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.